Medtronic plc Cash & Equivalents 2012-2026 | MDT
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Medtronic plc's current cash & equivalents?
Medtronic plc (MDT) annual cash & equivalents for 2025 was $2.22B, a 72.74% increase from 2024. Medtronic plc cash & equivalents for the quarter ending October 24, 2025 was $1.28B.
What was Medtronic plc's cash & equivalents in 2024?
Medtronic plc annual cash & equivalents for 2024 was $1.28B, a 16.79% decline from 2023.
What was Medtronic plc's cash & equivalents in 2023?
Medtronic plc annual cash & equivalents for 2023 was $1.54B, a 58.45% decline from 2022.
What is Medtronic plc's 5-year cash & equivalents CAGR?
Medtronic plc cash & equivalents grew at a compound annual growth rate (CAGR) of 11.73% from FY2020 to FY2025, going from $4.14B to $2.22B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-11.7%
FY2020
$4.14B
→
FY2025
$2.22B
1213141516171819202122232425
5 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.22B | +72.7% | 10-K |
| FY2024 | $1.28B | -16.8% | 10-K |
| FY2023 | $1.54B | -58.5% | 10-K |
| FY2022 | $3.71B | +3.4% | 10-K |
| FY2021 | $3.59B | -13.2% | 10-K |
| FY2020 | $4.14B | -5.8% | 10-K |
| FY2019 | $4.39B | +19.7% | 10-K |
| FY2018 | $3.67B | -26.1% | 10-K |
| FY2017 | $4.97B | +72.7% | 10-K |
| FY2016 | $2.88B | -40.6% | 10-K |
| FY2015 | $4.84B | +245.2% | 10-K |
| FY2014 | $1.40B | +52.7% | 10-K |
| FY2013 | $919.0M | -21.6% | 10-K |
| FY2012 | $1.17B | - | 10-K |
Company: Medtronic plcTicker: MDTSector: HealthcareIndustry: Electromedical & Electrotherapeutic ApparatusView company profile →